Evaluation of quick disintegrating calcium carbonate tablets
The purpose of this investigation was to develop a rapidly disintegrating calcium carbonate (CC) tablet by direct compression and compare it with commercially available calcium tablets. CC tablets were formulated on a Carver press using 3 different forms of CC direct compressed granules (Cal-Carb 4450®, Cal-Carb 4457®, and Cal-Carb 4462®). The breaking strength was measured using a Stokes-Monsanto hardness tester. The disintegration and dissolution properties of the tablets were studied using USP methodology. The calcium concentration was determined by an atomic absorption spectrophotometer. Scanning electron microscopy was used to evaluate the surface topography of the granules and tablets. Breaking strength of Cal-Carb 4450®, Cal-Carb 4457®, and Cal-Carb 4462® tablets was in the range of 7.2 to 7.7 kg, as compared with a hardness of 6.2 kg and 10 kg for the commercially available calcium tablets Citracal® and Tums®, respectively. The disintegration time for the tablets presented in the order earlier was 4.1, 2.1, 1.9, 2.9, and 9.7 minutes, respectively. The dissolution studies showed that all formulations released 100% of the elemental calcium in simulated gastric fluid in less than 20 minutes. In summary, this study clearly demonstrated that quick disintegrating CC tablets can be formulated without expensive effervescence technology.
KeywordsCalcium Carbonate Tablets Quick Disintegrating Effervescence
Unable to display preview. Download preview PDF.
- 1.Speckmann EW. What is the calcium requirement for optimal bone health? A workshop report.Proceedings of the XIII International Congress of Nutrition. Taylor TG, Jenkins NK, eds. London: John Libbey & Company Ltd.; 1985:580–583.Google Scholar
- 3.Recker RR, Bammi A, Barger-Lux MJ, Heaney RP. Calcium absorbability from milk products, an imitation milk and calcium carbonate.Am J Clin Nutr. 1988;47:93–95.Google Scholar
- 5.Peel N, Eastell R. ABC of rheumatology. Osteoporosis.Br Med J. 1995;310:989–992.Google Scholar
- 6.Walker R. General management of end stage renal disease.Br Med J. 1997;315:1429–1432.Google Scholar
- 7.Mayo M, Middleton RK. Calcium carbonate in hyperphosphatemia.DICP. 1991;25:945–947.Google Scholar
- 10.Whiting SJ, Pluhator MM. Comparison of in vitro and in vivo tests for determination of availability of calcium from calcium carbonate tablets.J Am Coll Nutr. 1992;11:553–560.Google Scholar
- 11.Mason NA, Patel JD, Dressman JB, Shimp LA. Consumer vinegar test for determining calcium disintegration.Am J Hosp Pharm. 1992;49:2218–2222.Google Scholar
- 14.Garf E, Ghanem AH, Mahmoud H, Abdel-Alim H. Studies on the direct compression of pharmaceuticals. Part 19, Effect of moisture on tablet physical parameters and bioavailability.Pharm Ind. 1986;48:292–295.Google Scholar
- 15.Chowhan ZT. The effect of low- and high-humidity aging on the hardness, disintegration time and dissolution rate of dibasic calcium phosphate-based tablets.J Pharm Pharmacol. 1980;32:10–14.Google Scholar
- 17.Nasipuri RN. Evaluation of cocoyam starch as tablet binder and disintegrant.Pharm Acta Helv. 1979;54:48–53.Google Scholar
- 18.Gazikalovic E, Obrenovic D, Nidzovic Z, Toskic-Radojicic M. Use of domestically produced corn starch in the manufacture of calcium carbonate tablets.Vojnosanit Pregl. 1988;55:407–10.Google Scholar
- 19.Makino T, Yamanka M, Kitamori N. Behavior of pregelatinized starch during granulation and its influence on tablet properties.Chem Pharm Bull. 1995;43:2264–2266.Google Scholar